Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.
about
Adjuvant treatment for older women with invasive breast cancerWeight Loss Randomized Intervention Trials in Female Cancer SurvivorsEverolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2- Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study.Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time PeriodsFactors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients.Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era.Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk AnalysisAnnual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases.Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy.Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence.Peri-operative biology in primary breast cancer: a credible therapeutic target.Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.The menopause specialist and breast cancer survivorship.Reconsidering axillary surgery for early breast cancer.Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer.Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patientsA Population-Based Cross-Sectional Study Comparing Breast Cancer Stage at Diagnosis between Immigrant and Canadian-Born Women in OntarioSET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment
P2860
Q28066744-50506636-F9F4-4660-BDC6-FC8377AE25B8Q33756419-A01DD579-DE87-4042-991B-CE54A7DE3488Q35675851-49EA8451-54D6-4B8E-9A3C-E9DC173CED63Q36051600-773BF10A-B7D4-4EFF-A56C-B6497F124708Q36070063-95AB8963-78FB-41D6-ADE8-EAEA8E475AD9Q36128131-DA6A79B2-2DB2-405E-AA7A-4572C9195E2CQ36546808-7D986263-5649-4CA5-A2B7-6B3B9BCD3BF5Q36849147-1535111C-976F-457E-94DF-2E9AD07D0E64Q37065597-BA204F99-A16B-42C9-80F0-EFCC32487225Q37241359-71FA9DDF-19D5-4026-8E0A-E4AFB2B9F66BQ37385681-428EC607-C7B4-4754-9DDF-40E9CE17043CQ37520235-12C83362-AADE-4E3F-8669-040FFE7BC782Q38573858-8681C048-04CE-4413-A6D1-4F476EAC56FFQ38658655-2B28388A-5C33-4E9D-992D-F9787C7BF544Q38788375-13644060-46A2-45FC-9978-70A8644697DFQ38855652-9DAD839C-B603-4B95-8A4C-1870E56C4EA6Q38955479-4BBC1917-1B5C-4327-8A56-266710F22CA9Q42331833-56C06E63-DE24-4A30-90FE-921B1B9F61DDQ47426563-87B00DBC-9CE3-4773-9148-BA604A3329A6Q52687764-9CCE07F5-D978-4A60-92D5-225DE3EF80A8Q54240388-10F21A81-7C43-4449-9989-A48908119575Q57491312-A86DCD9C-BD68-40D6-93AE-F717F8CCFF62Q58069180-35D0D2CB-696A-4B95-97F5-39014E5E5AECQ58697376-022258BD-F34F-41BB-9849-2C55FEFC0126
P2860
Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@en
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@nl
type
label
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@en
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@nl
prefLabel
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@en
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@nl
P2093
P356
P1476
Comparison of breast cancer re ...... to 1992 and from 2004 to 2008.
@en
P2093
Caroline H Speers
Karen A Gelmon
Rachel J D Cossetti
Scott K Tyldesley
Yvonne Zheng
P356
10.1200/JCO.2014.57.2461
P407
P577
2014-11-24T00:00:00Z